At this event, attendees will hear about AstraZeneca’s experience engaging with multiple technology providers to develop new products for transforming their sample management and screening programs. As AstraZeneca increases the diversity of its screening library, the ability to acoustically transfer nanoliter volumes of sample directly from low-volume storage tubes will enable the screening of rare or difficult to synthesize samples and reduce storage costs. Additionally, the rapid cherry-picking and plating of samples will enable a more efficient creation of target-specific libraries for iterative screening programs.
Attendees will also hear from leaders at Labcyte, Brooks, and Titian, who will describe how they have collaborated with AstraZeneca to bring to market a revolutionary sample management system capable of producing assay-ready plates for screening and other research applications, relying only on acoustic liquid handling to transfer samples directly from storage tubes.